Unraveling the Complex Role of MAPT-containing H1 and H2 Haplotypes in Neurodegenerative Diseases

Overview

Journal Mol Neurodegener

Publisher Biomed Central

Specialties Molecular Biology
Neurology

Date 2024 May 29

PMID 38812061

Authors

Chiara Pedicone

Sarah A Weitzman

Alan E Renton

Alison M Goate

Affiliations

Soon will be listed here.

Abstract

A ~ 1 Mb inversion polymorphism exists within the 17q21.31 locus of the human genome as direct (H1) and inverted (H2) haplotype clades. This inversion region demonstrates high linkage disequilibrium, but the frequency of each haplotype differs across ancestries. While the H1 haplotype exists in all populations and shows a normal pattern of genetic variability and recombination, the H2 haplotype is enriched in European ancestry populations, is less frequent in African ancestry populations, and nearly absent in East Asian ancestry populations. H1 is a known risk factor for several neurodegenerative diseases, and has been associated with many other traits, suggesting its importance in cellular phenotypes of the brain and entire body. Conversely, H2 is protective for these diseases, but is associated with predisposition to recurrent microdeletion syndromes and neurodevelopmental disorders such as autism. Many single nucleotide variants and copy number variants define H1/H2 haplotypes and sub-haplotypes, but identifying the causal variant(s) for specific diseases and phenotypes is complex due to the extended linkage equilibrium. In this review, we assess the current knowledge of this inversion region regarding genomic structure, gene expression, cellular phenotypes, and disease association. We discuss recent discoveries and challenges, evaluate gaps in knowledge, and highlight the importance of understanding the effect of the 17q21.31 haplotypes to promote advances in precision medicine and drug discovery for several diseases.

Citing Articles

DNA methylation as a contributor to dysregulation of and other frontotemporal lobar degeneration genetic risk-associated loci.

Rambarack N, Fodder K, Murthy M, Toomey C, de Silva R, Heutink P bioRxiv. 2025; .

PMID: 39975316 PMC: 11838521. DOI: 10.1101/2025.01.21.634065.

CNV-Finder: Streamlining Copy Number Variation Discovery.

Kuznetsov N, Daida K, Makarious M, Al-Mubarak B, Atterling Brolin K, Malik L bioRxiv. 2024; .

PMID: 39605431 PMC: 11601614. DOI: 10.1101/2024.11.22.624040.

Chronic overlapping pain conditions and nociplastic pain.

Johnston K, Signer R, Huckins L HGG Adv. 2024; 6(1):100381.

PMID: 39497418 PMC: 11617767. DOI: 10.1016/j.xhgg.2024.100381.

MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy.

Ressler H, Humphrey J, Vialle R, Babrowicz B, Kandoi S, Raj T Acta Neuropathol Commun. 2024; 12(1):135.

PMID: 39154163 PMC: 11330133. DOI: 10.1186/s40478-024-01839-3.

References

Hardy G . MENDELIAN PROPORTIONS IN A MIXED POPULATION. Science. 1908; 28(706):49-50. DOI: 10.1126/science.28.706.49. View

Bigoni S, Marangi G, Frangella S, Panfili A, Ognibene D, Squeo G . Clinical Genetics Can Solve the Pitfalls of Genome-Wide Investigations: Lesson from Mismapping a Loss-of-Function Variant in . Genes (Basel). 2020; 11(10). PMC: 7600039. DOI: 10.3390/genes11101177. View

Alonso A, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K . Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem. 2004; 279(33):34873-81. DOI: 10.1074/jbc.M405131200. View

Mahali S, Martinez R, King M, Verbeck A, Harari O, Benitez B . Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration. Transl Psychiatry. 2022; 12(1):508. PMC: 9734180. DOI: 10.1038/s41398-022-02274-5. View

Vargova R, Wideman J, Derelle R, Klimes V, Kahn R, Dacks J . A Eukaryote-Wide Perspective on the Diversity and Evolution of the ARF GTPase Protein Family. Genome Biol Evol. 2021; 13(8). PMC: 8358228. DOI: 10.1093/gbe/evab157. View

Dubourg C, Sanlaville D, Doco-Fenzy M, Le Caignec C, Missirian C, Jaillard S . Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation. Eur J Med Genet. 2010; 54(2):144-51. DOI: 10.1016/j.ejmg.2010.11.003. View

McEwan D, Popovic D, Gubas A, Terawaki S, Suzuki H, Stadel D . PLEKHM1 regulates autophagosome-lysosome fusion through HOPS complex and LC3/GABARAP proteins. Mol Cell. 2014; 57(1):39-54. DOI: 10.1016/j.molcel.2014.11.006. View

Liu G, Peng J, Liao Z, Locascio J, Corvol J, Zhu F . Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nat Genet. 2021; 53(6):787-793. PMC: 8459648. DOI: 10.1038/s41588-021-00847-6. View

Lakich D, Kazazian Jr H, Antonarakis S, Gitschier J . Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet. 1993; 5(3):236-41. DOI: 10.1038/ng1193-236. View

10.

Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N . New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54(4):412-436. PMC: 9005347. DOI: 10.1038/s41588-022-01024-z. View

11.

Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai H, Younkin C . Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels. Alzheimers Res Ther. 2014; 6(4):39. PMC: 4198935. DOI: 10.1186/alzrt268. View

12.

Karch C, Kao A, Karydas A, Onanuga K, Martinez R, Argouarch A . A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies. Stem Cell Reports. 2019; 13(5):939-955. PMC: 6895712. DOI: 10.1016/j.stemcr.2019.09.006. View

13.

Li T, Lu D, Yao C, Li T, Dong H, Li Z . Kansl1 haploinsufficiency impairs autophagosome-lysosome fusion and links autophagic dysfunction with Koolen-de Vries syndrome in mice. Nat Commun. 2022; 13(1):931. PMC: 8854428. DOI: 10.1038/s41467-022-28613-0. View

14.

Rogers B, Anderson A, Lauzon S, Davis M, Hauser R, Roberts S . Neuronal MAPT expression is mediated by long-range interactions with cis-regulatory elements. Am J Hum Genet. 2024; 111(2):259-279. PMC: 10870142. DOI: 10.1016/j.ajhg.2023.12.015. View

15.

Myers A, Pittman A, Zhao A, Rohrer K, Kaleem M, Marlowe L . The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis. 2006; 25(3):561-70. DOI: 10.1016/j.nbd.2006.10.018. View

16.

Park H, Chung S . New perspective on parkinsonism in frontotemporal lobar degeneration. J Mov Disord. 2014; 6(1):1-8. PMC: 4027647. DOI: 10.14802/jmd.13001. View

17.

Ferrari R, Hernandez D, Nalls M, Rohrer J, Ramasamy A, Kwok J . Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014; 13(7):686-99. PMC: 4112126. DOI: 10.1016/S1474-4422(14)70065-1. View

18.

Puig M, Lerga-Jaso J, Giner-Delgado C, Pacheco S, Izquierdo D, Delprat A . Determining the impact of uncharacterized inversions in the human genome by droplet digital PCR. Genome Res. 2020; 30(5):724-735. PMC: 7263195. DOI: 10.1101/gr.255273.119. View

19.

Barghorn S, Zheng-Fischhofer Q, Ackmann M, Biernat J, von Bergen M, Mandelkow E . Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry. 2000; 39(38):11714-21. DOI: 10.1021/bi000850r. View

20.

Ramos E, Dokuru D, Van Berlo V, Wojta K, Wang Q, Huang A . Genetic screen in a large series of patients with primary progressive aphasia. Alzheimers Dement. 2019; 15(4):553-560. PMC: 6480353. DOI: 10.1016/j.jalz.2018.10.009. View